Bnp Paribas Arbitrage, Snc »

Avalo Therapeutics Ord shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-03-31 $87 4 21.75

More positions owned by Bnp Paribas Arbitrage, Snc

Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
NVIDIA Corp Equity (NVDA)
Meta Platforms Equity (META)
Amazon.com Equity (AMZN)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Advanced Micro Devices Equity (AMD)
Industrial Select Sector SPDR Fund Fund (XLI)
Exxon Mobil Corp Equity (XOM)
iShares Russell 2000 ETF Fund (IWM)
Visa Equity (V)
JPMorgan Chase & Co Equity (JPM)
Alphabet Equity (GOOG)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Avalo Therapeutics Ord

Ikarian Capital
Sio Capital Management
UBS Group
ADAR1 Capital Management
Natixis
BlackRock
Tower Research Capital
Banque Cantonale Vaudoise
Royal Bank of Canada
Morgan Stanley
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc
Group One Trading
Jpmorgan Chase & Co
Advisor Group Holdings

View all funds holding Avalo Therapeutics Ord